GlassScriptPhysician profile
Jonathan Burkes
NPI 1538571609
$7,983.09
in general payments reported to CMS, 2019-2025
20 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,584 · 2020: $400 · 2021: $308 · 2022: $214 · 2023: $2,737 · 2024: $1,660 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,931 · Travel and Lodging: $2,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,930.61 |
| Travel and Lodging | $2,546.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,239.28 | 2019-2025 | Actishield, Axsos, T2 Alpha |
| Smith+Nephew, INC. | $3,116.59 | 2021-2025 | Journey, Or3o Dual Mobility, Ri Hip Navigation |
| Pacira Pharmaceuticals Incorporated | $279.07 | 2019-2025 | Exparel, Iovera, Zilretta |
| Medical Device Business Services, INC. | $259.99 | 2019 | |
| Depuy Synthes Sales INC. | $206.52 | 2020-2023 | Actis |
| Ethicon US, LLC | $182.31 | 2024-2025 | Vistaseal, Prolene, Surgiflo Hemostatic Matrix |
| Horizon Therapeutics Plc | $139.61 | 2020-2021 | |
| Becton, Dickinson and Company | $113.99 | 2025 | Bd Phaseal |
| Heron Therapeutics, INC. | $95.85 | 2023 | Zynrelef |
| Pacira Therapeutics, INC. | $67.57 | 2020-2021 | |
| Amgen INC. | $48.18 | 2024-2025 | Krystexxa |
| Biomerieux INC | $44.20 | 2023 | |
| Onkos Surgical, INC. | $42.11 | 2021 | |
| Integra Lifesciences Corporation | $38.96 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Orthofix Medical, INC. | $25.50 | 2024-2025 | Physio-Stim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $25.16 | 2024 | Entre Plus, Flexitouch Plus |
| Vertex Pharmaceuticals Incorporated | $20.47 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $14.70 | 2022 | |
| Bioventus LLC | $13.74 | 2022 | |
| Advanced Oxygen Therapy INC. | $9.29 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Burkes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.